DK407488D0 - Fremgangsmaade til behandling af overskud af jern - Google Patents

Fremgangsmaade til behandling af overskud af jern

Info

Publication number
DK407488D0
DK407488D0 DK407488A DK407488A DK407488D0 DK 407488 D0 DK407488 D0 DK 407488D0 DK 407488 A DK407488 A DK 407488A DK 407488 A DK407488 A DK 407488A DK 407488 D0 DK407488 D0 DK 407488D0
Authority
DK
Denmark
Prior art keywords
iron
profits
treating
procedure
mammal
Prior art date
Application number
DK407488A
Other languages
English (en)
Other versions
DK167650B1 (da
DK407488A (da
Inventor
John W Adamson
Joseph W Eschbach
Michael R Downing
Joan C Egrie
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Publication of DK407488D0 publication Critical patent/DK407488D0/da
Publication of DK407488A publication Critical patent/DK407488A/da
Application granted granted Critical
Publication of DK167650B1 publication Critical patent/DK167650B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Manufacture Of Iron (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Iron (AREA)
  • Hydrogen, Water And Hydrids (AREA)
DK407488A 1986-11-21 1988-07-21 Anvendelse af erythropoietin til fremstilling af et laegemiddel mod jernoverskudsrelaterende lidelser DK167650B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/933,495 US5013718A (en) 1986-11-21 1986-11-21 Method for treating iron overload using EPO
US93349586 1986-11-21
PCT/US1987/002673 WO1988003808A1 (en) 1986-11-21 1987-10-19 Method for treating iron overload
US8702673 1987-10-19

Publications (3)

Publication Number Publication Date
DK407488D0 true DK407488D0 (da) 1988-07-21
DK407488A DK407488A (da) 1988-07-21
DK167650B1 DK167650B1 (da) 1993-12-06

Family

ID=25464076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK407488A DK167650B1 (da) 1986-11-21 1988-07-21 Anvendelse af erythropoietin til fremstilling af et laegemiddel mod jernoverskudsrelaterende lidelser

Country Status (16)

Country Link
US (1) US5013718A (da)
EP (1) EP0269394B1 (da)
JP (1) JPH0692316B2 (da)
KR (1) KR950009100B1 (da)
AT (1) ATE68352T1 (da)
AU (1) AU602028B2 (da)
CA (1) CA1322165C (da)
DE (1) DE3773852D1 (da)
DK (1) DK167650B1 (da)
ES (1) ES2039252T3 (da)
GR (1) GR3003254T3 (da)
IE (1) IE60865B1 (da)
IL (1) IL84275A (da)
NZ (1) NZ222432A (da)
PT (1) PT86187B (da)
WO (1) WO1988003808A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880012235A (ko) * 1987-04-10 1988-11-26 벤자민 에프.람버트 정상 포유동물의 헤마토크릿을 증가시키는 방법
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6012450A (en) * 1993-01-29 2000-01-11 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
WO1996014081A1 (en) * 1994-11-03 1996-05-17 Boehringer Mannheim Gmbh Use of erythropoietin in the treatment of rheumatoid arthritis
WO1996030068A1 (en) 1995-03-31 1996-10-03 Aradigm Corporation Intrapulmonary delivery of hematopoietic drug
TW586933B (en) * 1996-06-20 2004-05-11 Chugai Pharmaceutical Co Ltd Compositions for treating liver-complaints using EPO
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
AR019025A1 (es) 1998-04-09 2001-12-26 Roche Diagnostics Gmbh Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
EP0965349A1 (de) * 1998-06-18 1999-12-22 Roche Diagnostics GmbH Verwendung von Erythropoietin zur Behandlung von Hämochromatosen
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
DE19857609A1 (de) * 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
WO2001035095A2 (en) * 1999-11-12 2001-05-17 Rothenberg Barry E Diagnostic test for hemochromatosis
US7160855B2 (en) * 2002-03-14 2007-01-09 Children's Hospital & Research Center At Oakland Enhancement of iron chelation therapy
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
US7611700B2 (en) * 2002-09-09 2009-11-03 Hanall Pharmaceuticals, Co., Ltd. Protease resistant modified interferon alpha polypeptides
JP2010510794A (ja) 2006-11-28 2010-04-08 ハナル ファーマシューティカル カンパニー リミテッド 修飾型エリスロポエチンポリペプチド及びこの治療用用途
US10694961B2 (en) 2011-06-13 2020-06-30 Cedaris-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
US10694962B2 (en) 2011-06-13 2020-06-30 Cedars-Sinai Medical Center Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage
FR3037592B1 (fr) 2015-06-18 2017-06-09 Michelin & Cie Pneumatique pourvu d'une bande de roulement comprenant un elastomere dienique et un systeme d'elastomeres thermoplastiques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4667016A (en) * 1985-06-20 1987-05-19 Kirin-Amgen, Inc. Erythropoietin purification

Also Published As

Publication number Publication date
DE3773852D1 (de) 1991-11-21
IL84275A (en) 1993-04-04
ES2039252T3 (es) 1993-09-16
IE873113L (en) 1988-05-21
DK167650B1 (da) 1993-12-06
ATE68352T1 (de) 1991-11-15
EP0269394B1 (en) 1991-10-16
WO1988003808A1 (en) 1988-06-02
US5013718A (en) 1991-05-07
PT86187A (en) 1987-12-01
IE60865B1 (en) 1994-08-24
DK407488A (da) 1988-07-21
EP0269394A2 (en) 1988-06-01
NZ222432A (en) 1990-07-26
GR3003254T3 (en) 1993-02-17
KR950009100B1 (ko) 1995-08-14
AU602028B2 (en) 1990-09-27
KR890700032A (ko) 1989-03-02
PT86187B (pt) 1990-11-07
EP0269394A3 (en) 1988-09-14
JPS63159322A (ja) 1988-07-02
CA1322165C (en) 1993-09-14
AU8179487A (en) 1988-06-16
JPH0692316B2 (ja) 1994-11-16

Similar Documents

Publication Publication Date Title
DK407488D0 (da) Fremgangsmaade til behandling af overskud af jern
PT87086A (pt) Active specific immune suppression
ATE57948T1 (de) Lichtinduziertes toeten von karzinomzellen.
NO173146C (no) Fremgangsmaate ved syrebehandling av en underjordisk formasjon
KR880701736A (ko) Il-6의 제조방법 및 용도
EP0179390A3 (de) L-Lysin- und L-Histidinpyruvat
DK344485D0 (da) Hidtil ukendt behandlingsmetode
DK344585D0 (da) Hidtil ukendt behandlingsmetode
JPS5230447A (en) Method of connecting optical fibers
DK194288D0 (da) Fremgangsmaade til foroegelse af et normalt pattedyrs haematokrit
BR8107935A (pt) Celula eletrolitica cloro-alcalina;celula de prensa-filtro;processo de recirculacao de eletrolito
ATE60322T1 (de) Verfahren zur herstellung von 2-amino-3-nitro-6(4-fluor-benzyl-amino)-pyridin sowie 2-amino-3de850323
FI832252L (fi) Foerbaettrat foerfarande foer produktion av interferon
SE429091B (sv) Forfarande for behandling av cellprotein for att reducera halten nukleinsyra i cellerna
BR8005159A (pt) Celula fotovoltaica e processo de formacao e ligacao de eletrodo
FR2260330A1 (en) Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
DE3583625D1 (de) Erzeugung von bauholz.
JPS51127743A (en) Optical fiber and its manufacturing method
DK108984D0 (da) Anvendelse af copolymere af 2-acrylamido-2-methylpropansulfonsyre til forbedring af retention og afvanding ved papirfremstilling
SU583980A1 (ru) Способ подготовки стекольной шихты
SU1597005A1 (ru) Способ получения радионуклида иод-123
ES428172A1 (es) Un procedimiento para preparar acido 5-pivaloiloxi-5-(1-fe-niletil)-barbiturico.
ES457992A1 (es) Un procedimiento para preparar nuevas sales por adicion de acido del d-(+)-1-(3-hidroxifenil)-2-aminopropano.
JPS6464360A (en) Gto thyristor
UA14057A1 (uk) Спосіб підвищеhhя стійкості ссавців до загальhого охолоджеhhя

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired